AU Patent

AU2014284268A1 — Compounds for treatment of cystic fibrosis

Assigned to California Institute for Biomedical Research · Expires 2016-01-07 · 10y expired

What this patent protects

Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.

USPTO Abstract

Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.

Drugs covered by this patent

Patent Metadata

Patent number: AU2014284268A1
Jurisdiction: AU
Classification: —
Expires: 2016-01-07
Drug substance claim: No
Drug product claim: No
Assignee: California Institute for Biomedical Research
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.